确定痴呆日常功能的最小重要变化:追求临床意义
研究通过照护者与临床医生调查确定阿姆斯特丹工具性日常生活活动问卷的最小重要变化阈值:下降为-2.2分,改善为+5.0分。在230例记忆门诊患者中随访1年,45%出现超过阈值的下降,痴呆诊断与内侧颞叶萎缩是预测因素。
要点
- 最小重要变化阈值:下降-2.2分,改善+5.0分(阿姆斯特丹IADL问卷)。
- 230例记忆门诊患者随访1年,102例(45%)出现超过阈值的功能下降。
- 痴呆诊断(OR=3.4)和内侧颞叶萎缩(OR=5.0)预测功能下降超过阈值。
核心结论
- 通过确定最小重要变化,可将工具性日常生活活动的临床意义下降操作化。
- 近半数未选择的记忆门诊患者在不到一年内出现有意义的功能下降,支持该阈值的实用性。
- 疾病阶段和内侧颞叶萎缩是功能下降超过最小重要变化的预测因素。
研究设计与样本
- 研究分两部分:第一部分为定性调查,社区招募的ADRD患者非正式照护者(N=1,629)和记忆门诊临床医生(N=13)判断日常功能变化情境;第二部分为独立纵向队列研究,纳入未选择的记忆门诊患者(N=230),随访1年。
主要发现
- 最小重要变化阈值取照护者与医生判断的平均值:下降为-2.2分,改善为+5.0分(阿姆斯特丹IADL问卷)。
- 记忆门诊患者(N=230;64.3±7.7岁;39%女性;60%痴呆诊断)随访1年,102例(45%)在平均6.7±3.5个月时出现超过最小重要变化的下降。
- 痴呆诊断患者功能下降超过阈值的 odds ratio(OR)=3.4,95% CI [1.5-7.8];内侧颞叶萎缩更明显者 OR=5.0,95% CI [1.2-20.0],均高于主观认知抱怨且无萎缩者。
关键数值与推荐
- 阿姆斯特丹IADL问卷最小重要变化:临床意义下降阈值为-2.2分,临床意义改善阈值为+5.0分。
临床怎么用
- 研究结果可为解读IADL变化提供参考,并可能有助于评估治疗效果和监测疾病进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Decline in everyday functioning is a key clinical change in Alzheimer disease and related disorders (ADRD). An important challenge remains the determination of what constitutes a clinically meaningful change in everyday functioning. We aimed to investigate this by establishing the minimal important change (MIC): the smallest amount of change that has a meaningful effect on patients' lives. We retrospectively investigated meaningful change in a memory clinic cohort. METHODS: In the first, qualitative part of the study, community-recruited informal caregivers of patients with ADRD and memory clinic clinicians completed a survey in which they judged various situations representing changes in everyday functioning. Their judgments of meaningful change were used to determine thresholds for MIC, both for decline and improvement, on the Amsterdam Instrumental Activities of Daily Living (IADL) Questionnaire. In the second, quantitative part, we applied these values in an independent longitudinal cohort study of unselected memory clinic patients. RESULTS: MIC thresholds were established at the average threshold of caregivers (N = 1,629; 62.4 ± 9.5 years; 77% female) and clinicians (N = 13): -2.2 points for clinically meaningful decline and +5.0 points for clinically meaningful improvement. Memory clinic patients (N = 230; 64.3 ± 7.7 years; 39% female; 60% dementia diagnosis) were followed for 1 year, 102 (45%) of whom showed a decline larger than the MIC, after a mean of 6.7 ± 3.5 months. Patients with a dementia diagnosis and more atrophy of the medial temporal lobe had larger odds (odds ratio [OR] = 3.4, 95% CI [1.5-7.8] and OR = 5.0, 95% CI [1.2-20.0], respectively) for passing the MIC threshold for decline than those with subjective cognitive complaints and no atrophy. DISCUSSION: We were able to operationalize clinically meaningful decline in IADL by determining the MIC. The usefulness of the MIC was supported by our findings from the clinical sample that nearly half of a sample of unselected memory clinic patients showed a meaningful decline in less than a year. Disease stage and medial temporal atrophy were predictors of functional decline greater than the MIC. Our findings provide guidance in interpreting changes in IADL and may help evaluate treatment effects and monitor disease progression.
引用
- Dubbelman MA, Verrijp M, Terwee CB, et al. Determining the Minimal Important Change of Everyday Functioning in Dementia: Pursuing Clinical Meaningfulness. Neurology. 2022. PMID: 35641309. doi:10.1212/WNL.0000000000200781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。